Deutsche Bank
TEVA icon

Deutsche Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Deutsche Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-50
Closed -$2K – 5894
2014
Q4 		$2K Sell
50
-550
-92% -$30.6K ﹤0.01% 6015
2014
Q3 		$32K Sell
600
-1,341
-69% -$71K ﹤0.01% 5045
2014
Q2 		$101K Sell
1,941
-3,230
-62% -$165K ﹤0.01% 4564
2014
Q1 		$1K Buy
5,171
+3,320
+179% +$153K ﹤0.01% 5482
2013
Q4 		$3K Buy
+1,851
New +$72.9K ﹤0.01% 5127

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's TEVA Position: Q1 2026 in Review

Deutsche Bank increased its Teva Pharmaceuticals (TEVA) stake by 13% in Q1 2026, buying an estimated $10.2M and bringing the position to 2,829,970 shares worth $85.2M. The position accounts for 0.03% of the portfolio, ranked #521.

Deutsche Bank first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $193M in Q2 2015. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Deutsche Bank held 2,829,970 shares of Teva Pharmaceuticals worth $85.2M as of Q1 2026.
  • Deutsche Bank bought 318,314 Teva Pharmaceuticals shares in Q1 2026, an estimated $10.2M.
  • Teva Pharmaceuticals made up 0.03% of Deutsche Bank's portfolio in Q1 2026, its #521 holding.
  • Deutsche Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Teva Pharmaceuticals position peaked at $193M in Q2 2015.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.